Brief: Abeona Therapeutics Announces Progress Update On Pz-Cel Biologics License Application (BLA)
Feb 1 (Reuters) - Abeona Therapeutics Inc ABEO.O :
* ABEONA THERAPEUTICS ANNOUNCES PROGRESS UPDATE ON PZ-CEL
BIOLOGICS LICENSE APPLICATION (BLA)
* ABEONA THERAPEUTICS INC - ON TRACK FOR PDUFA TARGET ACTION
DATE
OF MAY 25, 2024
* ABEONA THERAPEUTICS INC - FDA REAFFIRMED ITS EARLIER
INDICATION
THAT IT DOES NOT CURRENTLY PLAN TO CONVENE AN ADVISORY COMMITTEE
FOR PZ-CEL
Source text for Eikon: ID:nGNX67jqNZ
Further company coverage: ABEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports